Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Fitzgerald, IE

Alan Fitzgerald, Edgeworthstown IE

Patent application numberDescriptionPublished
20100283238Discriminating Fluid Connection System - A discriminating connector system for medical use. The connector system includes a male connector and a female connector. A standoff of the male connector forms a sealed, fluid connection with a receptacle of the female connector for fluid flow between conduits connected to the male and female connectors. The construction of the connector system prevents connection of either the male or female connector to other non-conforming connectors or syringes commonly found in medical environments, such as male and female luer-lock connectors and syringes.11-11-2010

Alan Fitzgerald, Longford IE

Patent application numberDescriptionPublished
20100286650Medical Fluid Container - A medical fluid container is disclosed that comprises a single reservoir of fluid impermeable material having a fluid impermeable barrier dividing the reservoir into at least first and second fluid-holding compartments. A valve is selectively movable to allow flow of fluid from the compartments. A method of dispensing medical fluids from a medical fluid container is also disclosed.11-11-2010

Ciara Bridget Fitzgerald, County Meath IE

Patent application numberDescriptionPublished
20090004451Thin Magnetic Films - A composite comprises a substrate and a fluoride, oxide, nitride or boride of a substantially non-magnetic cation on the substrate, the composite exhibiting ferromagnetic properties at room temperature. The composite may be in the form of a film.01-01-2009

Desmond Joseph Fitzgerald, Dublin IE

Patent application numberDescriptionPublished
20110033474INHIBITION OF PLATELET AGGREGATION - The present invention provides methods and compositions for preventing platelet aggregation and for treating individuals suffering from conditions or undergoing procedures that may result in unwanted platelet aggregation. In particular the invention provides to methods and compositions for arterial vessel pacification. The methods are based on the administration of a therapeutically effective amount of a glycoprotein IIb/IIIa receptor antagonist, e.g., xemilofiban. The treatment may commence prior to a medical or surgical procedure or an outbreak of a condition, either of which results in the activation of platelets that may lead to thrombus formation, and may continue thereafter.02-10-2011

Diarmaid Fitzgerald, Dublin IE

Patent application numberDescriptionPublished
20110137213METHOD AND SYSTEM FOR THERAPEUTIC EXERGAMING - A computer program product comprising a non-transitory computer readable medium for storing or recording instructions in machine readable form. The instructions, when executed in a motion sensor enabled smart phone, record target data associated with a response of the motion sensor to a desired sequence of movements of a user performing a therapeutic exercise while wearing the smart phone, map the target data to run-time target parameters of a software application, receive performance data associated with a response of the motion sensor to a subsequent sequence of movements of the user performing the therapeutic exercise while wearing the smart phone, map the performance data to the target parameters of the software application to determine the operation of the software application and provide information for display on a remote monitor visible to the user indicating the quality of the user's performance of the exercise.06-09-2011

Dick Fitzgerald, Limerick IE

Patent application numberDescriptionPublished
20100305050PROTEIN PRODUCT WITH MODIFIED ANTIGENICITY - A bovine casein protein hydrolysate prepared using an enzyme having broad spectrum endopeptidase activity has low residual antigenicity properties in mammals compared to intact casein protein, The composition is useful as an ingredient in foods, beverages, pharmaceutical and cosmetic products. A hydrolysate prepared using Alcalaseā„¢ with a degree of hydrolysis of 19.88% has very desirably low antigenicity characteristics.12-02-2010
20110130637PROTEIN PRODUCT FOR MODIFYING CARDIOVASCULAR HEALTH - A composition for use in the treatment or prophylaxis of conditions mediated by endothelial function in mammals is provided. The composition includes a milk protein hydrolysate generated by treating milk or milk whey protein with a proteolytic enzyme having subtilisin or subtilisin-like activity and/or glutamyl endopeptidase or glutamyl endopeptidase-like activity. The composition is useful in the management of vascular conditions.06-02-2011

Ger Fitzgerald, Co. Cork IE

Patent application numberDescriptionPublished
20090214498ANTIMICROBIAL PEPTIDES AND BACTERIAL STRAINS THAT PRODUCE THEM - The present invention relates generally to the field of health promoting agents, in particular antimicrobial agents and provides antimicrobial peptides and bacterial strains that provide the antimicrobial peptides. In one aspect, the invention provides a biologically pure culture of 08-27-2009

Ger Fitzgerald, Cork IE

Patent application numberDescriptionPublished
20100047209Probiotic composition suitable for animals - The invention provides a probiotic composition to alleviate 02-25-2010

Joseph Fitzgerald, Westmeath IE

Patent application numberDescriptionPublished
20100162599Flame Effect Fire - A flame effect assembly is described. By using an adhesive to secure a fabric to at least one track and then defining a plurality of flag elements within the fabric by forming two or more slits in the fabric it is possible to substantially optimise the assembly process.07-01-2010

Lawrence William Paul Fitzgerald, Limerick IE

Patent application numberDescriptionPublished
20080265016System and a Method for Facilitating Paying for a Parking Permit in a Selected One of One or More Pay-for-Parking Zones10-30-2008

Michael Fitzgerald, County Kerry IE

Patent application numberDescriptionPublished
20110256864 COMMUNICATIONS SYSTEM AND METHOD - A method of operation of a mobile network (10-20-2011

Padraig Fitzgerald, Co. Cork IE

Patent application numberDescriptionPublished
20100155202MICRO-ELECTRO-MECHANICAL SWITCH BEAM CONSTRUCTION WITH MINIMIZED BEAM DISTORTION AND METHOD FOR CONSTRUCTING - Disclosed is a micro-electro-mechanical switch, including a substrate having a gate connection, a source connection, a drain connection and a switch structure, coupled to the substrate. The switch structure includes a beam member, an anchor and a hinge. The beam member having a length sufficient to overhang both the gate connection and the drain connection. The anchor coupling the switch structure to the substrate, the anchor having a width. The hinge coupling the beam member to the anchor at a respective position along the anchor's length, the hinge to flex in response to a charge differential established between the gate and the beam member. The switch structure having gaps between the substrate and the anchor in regions proximate to the hinges.06-24-2010
20110019330CONTROL TECHNIQUES FOR ELECTROSTATIC MICROELECTROMECHANICAL (MEM) STRUCTURE - Disclosed are a method, device, and system for a microelectromechanical (MEM) device control system that can control the operation of a MEM device. The system can include a microelectromechanical device and a control circuit. The micromechanical device can include a moveable member coupled to an electrical terminal, a sensor, responsive to a movement of the moveable member, can output a sensor signal based on the movement of the moveable member, and an actuating electrode for receiving a control signal. The control circuit can be responsive to the signals output by the sensor and outputs the control signal to the actuating electrode.01-27-2011

Padraig Fitzgerald, Mallow IE

Patent application numberDescriptionPublished
20100068854MEMS Switch Capping and Passivation Method - A MEMS switch with a platinum-series contact is capped through a process that also passivates the contact by controlling, over time, the amount of oxygen in the environment, pressures and temperatures. Some embodiments passivate a contact in an oxygenated atmosphere at a first temperature and pressure, before hermetically sealing the cap at a higher temperature and pressure. Some embodiments hermetically seal the cap at a temperature below which passivating dioxides will form, thus trapping oxygen within the volume defined by the cap, and later passivate the contact with the trapped oxygen at a higher temperature.03-18-2010
20100187076MICRO-ELECTRO-MECHANICAL SWITCH BEAM CONSTRUCTION WITH MINIMIZED BEAM DISTORTION AND METHOD FOR CONSTRUCTING - Disclosed is a micro-electro-mechanical switch, including a substrate having a gate connection, a source connection, a drain connection and a switch structure, coupled to the substrate. The switch structure includes a beam member, an anchor, an anchor beam interface and a hinge. The beam member having a length sufficient to overhang both the gate connection and the drain connection. The anchor coupling the switch structure to the substrate. The anchor beam interface coupling the anchor to the hinge. The hinge coupling the beam member to the anchor at a respective position along the anchor's length, the hinge to flex in response to a voltage differential established between the gate and the beam member. The switch structure having gaps between the substrate and the anchor in regions proximate to the hinges.07-29-2010
20110287586MEMS Switch Capping and Passivation Method - A MEMS switch with a platinum-series contact is capped through a process that also passivates the contact by controlling, over time, the amount of oxygen in the environment, pressures and temperatures. Some embodiments passivate a contact in an oxygenated atmosphere at a first temperature and pressure, before hermetically sealing the cap at a higher temperature and pressure. Some embodiments hermetically seal the cap at a temperature below which passivating dioxides will form, thus trapping oxygen within the volume defined by the cap, and later passivate the contact with the trapped oxygen at a higher temperature.11-24-2011

Padraig Liam Fitzgerald, Co. Cork IE

Patent application numberDescriptionPublished
20090256531CHARGE INJECTION DISCHARGE CIRCUIT - Disclosed is a method and circuit for dissipating injected parasitic charge including a circuit stage, a pulse generating circuit and a switch. The circuit stage having an input node and an output node that injects a parasitic charge when switched OFF to the output node. The pulse generating circuit can generate a pulsed signal having an input for receiving a control signal. The control signal indicates the circuit stage is switching OFF, and has an output for outputting a pulsed signal in response to the control signal at the input. The pulsed signal can have a predetermined duration. The switch can be configured to be actuated by the pulsed signal output by the pulse generating circuit, and having a terminal connected to the output node of the circuit stage and a terminal connected to circuit to substantially dissipate the injected parasitic charge.10-15-2009

Pat Fitzgerald, Co Kilkenny IE

Patent application numberDescriptionPublished
20080320628Variety of Phormium plant named 'FIT01" - A new and distinct cultivar of 12-25-2008

Patrick Fitzgerald, Stoneyford IE

Patent application numberDescriptionPublished
20090126053Variety of Ceanothus plant named 'FIT02' - A new cultivar of 05-14-2009
20090222963Carex plant named 'CarFit01' - A new and distinct 09-03-2009

Peter Fitzgerald, Co. Antrim IE

Patent application numberDescriptionPublished
20080206780Antibody Libraries - The invention relates to a composition comprising a plurality of antibody fragments, each comprising a framework region having a murine VH14 heavy chain and a murine VK2 light chain, or homologues thereof, each antibody fragment further comprising at least one different CDR.08-28-2008

Stephen Peter Fitzgerald, Antrim IE

Patent application numberDescriptionPublished
20090053824Assay Device Processing Apparatus and Method - Assay device processing apparatus includes a rotatably mounted assay device vessel support; and a drive for rotating the support. The support is rotatable about a substantially horizontal first axis so that, upon rotation, an assay device vessel attached to the support can be inverted.02-26-2009

Stephen Peter Fitzgerald, Co.antrim IE

Patent application numberDescriptionPublished
20090192107Breast Cancer Markers - A method for the detection of the presence of or the risk of cancer in a patient, comprising, with reference to a normal control, the step of: (i) detecting the expression level of a gene characterised by any of the nucleotide sequences identified herein as SEQ ID No. 1 to SEQ ID No. 10, in a sample isolated from a patient, wherein an increased expression level of the gene characterised by any of SEQ ID Nos. 1 to 6 and 10, or a decreased expression level of the gene characterised by any of SEQ ID Nos. 7 to 9, indicates the presence of or the risk of cancer in the patient from whom the sample was isolated.07-30-2009

Stephen Peter Fitzgerald, Crumlin IE

Patent application numberDescriptionPublished
20120094316Drug Detection - The invention relates to an immunoassay method and kit for the detection and/or the determination of mephedrone, mephedrone metabolites and related compounds. The invention is underpinned by a novel antibody, derived from a novel immunogen, that is sensitive and binds to mephedrone, mephedrone metabolites and related compounds.04-19-2012